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Abstract: Cathelicidin Pc-CATH1 is a cathelicidin-derived myeloid antimicrobial peptide identified from Phasianus colchicus with 
strong antimicrobial activity against most of bacteria and fungi tested, including the clinically isolated (IS) drug-resistant strains. 
Considering the uniform distribution of net positive charge in both C- and N-terminus sequence of cathelicidin Pc-CATH1 and most 
of hydrophobic amino acid (aa) residues positioned in middle of the sequence, the antimicrobial peptide was used to investigate the 
structure-function relationship by truncating gradually N- or C-terminus amino acid residue. More than 10 modified peptide homo-
logues (20–26 aa length) of cathelicidin Pc-CATH1 were found to keep strong antimicrobial abilities. The possible relationships 
between bioactivities including antimicrobial and hemolytic abilities, components of secondary structure, hydrophobicity,  
amphipathicity, net charge, and sequence length were investigated. The current work provided suggestions for structural and  
functional modification of linear, α-helical antimicrobial peptides containing no disulfided bridges. 
Keywords: cathelicidin, antimicrobial peptide, structure-function relationship 
Introduction 
Antimicrobial peptides are important components of the 
innate immunity system, which is the first line of host defense 
protecting living organisms from microorganism attacking. 
These molecules are gene-encoded, cationic, and have a broad 
activity against bacteria, fungi, virus, and even some tumor 
cells. The diversity of antimicrobial peptides is very rich. 
Based on the amino acid sequence and secondary structure, 
they are classified into several groups. In mammals, 
cathelicindin and defensin are the two main antimicrobial 
peptide groups1,2. 
Cathelicidin is synthesized as pre-pro-protein containing a 
N-terminal signal domain, a highly conserved cathelin domain, 
and the varible C-terminal peptide3. Cathelicidin is named for 
the cathelin domain as it is very similar to cathelin protein, a 
cathepsin L inhibitor originally isolated from pig leucocytes4. 
The variable C-terminal peptide is mature peptide. It is  
considerably diverse in amino acid sequence. Based on the 
structure of mature peptide, cathelicidin can be classified into 
three groups, linear, α-helical peptides without cysteine, β-
hairpin peptides with cysteines by disulphides, peptides rich in 
one or two amino acids. As the active region, the mature  
peptides display typical features of antimicrobial peptide,  
cationic and amphipathic, cathelicidin Pc-CATH1 is a  
potential antimicrobial peptide found in P. colchicus. Most 
MIC values against Gram-positive bacteria were in the range 
of 0.09–2.95 μM in the presence of 100 mM NaCl6. Two  
obvious characteristics are found in the sequence of cathelicidin
Pc-CATH1. One is the uniform distribution of three positive 
charged amino acid residues (Arg or Lys) in both C- and N-
terminus sequence. Another one is that most of the hydrophobic
amino acid residues are positioned in the middle of the  
sequence. The unique structural characteristic of cathelicidin 
Pc-CATH1 provide excellent template to study the structure-
function relationship. 
 
Results and Discussion 
Cathelicidin Pc-CATH1 and its 29 homologues were listed 
in Table 1. They are 11–26 aa in length. There are 4–8 net 
positive charges. Their hydrophobicity is from 0.122 to 0.640. 
The hydrophobic moment ranges from 0.285 to 0.645. The 
percent ratio of nonpolar residues is from 50% to 66.67%.  
*To whom correspondence should be addressed. E-mail: 
dhlin@xmu.edu.cn (D.H. Lin); rlai@mail.kiz.ac.cn (R. Lai). 
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There are no acidic residues in these peptides. As illustrated in 
Fig. 1. All of LR homologues (LR1–LR16) and most of RL 
homologues show the amphipathicity, with the hydrophobic 
residues in the lower regions and the hydrophilic residues in 
the upper regions. Some of RL homologues, such as RL11–14, 
are hydrophilic, and are not amphipathic. 
To investigate the secondary structures of cathelicidin Pc-
CATH1 and its homologues in membrane-like environments, 
the CD spectra of these peptides were analyzed at a variety of 
membrane-mimicking conditions (Fig. 2). As shown in Fig. 
2A, these peptides showed unordered structures in aqueous 
solution; main secondary components are random and -sheet. 
These peptides exhibited conformational changes in SDS  
micelles. There are high percent (> 25%) α-helical structure 
component in most of these peptides resolved in all  
membrane-mimetic environments. Their CD spectrum exhibited
characteristic double negative maxima at 205 and 220 nm, 
suggesting that it can adopt a significant degree of α-helical 
structure under these conditions. These results suggest that 
most of these peptides have a more folded structure in  
negatively charged environments due to electrostatic  
interaction. Some peptides (LR11–16, RL14) adopt a lower 
degree of α-helical structure in SDS micelles. 
The antimicrobial activities of cathelicidin Pc-CATH1 and 
its 29 homologues against a representative set of bacterial and 
fungi strains, including S. aureus, B. subtilis, E. coli, and C. 
albicans were assayed as listed in Table 2, and compared with 
the activities of amphicillin. Nine peptides including LR1–4 
and RL1–5 showed strong  antimicrobial activities. Most of 
the MICs against all the four microorganisms were less than 
10 g/mL. Especially, the MICs against C. albicans were 
0.586 to 7.032 g/mL. It seems that these peptides showed the 
strongest antimicrobial abilities against the fungus, C. albicans. 
For S. aureus, RL1–5 (MICs 1.172–14.063 g/mL) showed 
stronger antimicrobial activities than LR1-4 did (MICs 7.032–
37.5 g/mL). LR5 showed antimicrobial abilities against three 
tested microorganism strains including S. aureus, E. coli, and 
C. albicans but B. subtilis. LR6–8 showed antimicrobial 
abilities against two tested microorganism strains including E. 
coli, and C. albicans. RL6 contained antimicrobial activities 
against both S. aureus and C. albicans. LR9–11, LR13, LR15 
and 16, RL7 and 8 showed antimicrobial activities against only 
C. albicans. For LR peptides, only LR12 and LR14 had no 
antimicrobial activity. 
As illustrated in Fig. 3, several cathelicidin Pc-CATH1 
homologues showed strong hemolytic activities against human 
blood red cells. LR1–3 and RL1–4 showed much stronger 
hemolytic activities than other cathelicidin Pc-CATH1 homo-
logues. At the concentration of 200 g/mL, LR1–3 induced 
approximate 30%, 26%, and 25% hemolysis of human blood 
red cells, respectively; RL1–4 induced approximate 24%, 48%, 
58%, and 57% hemolysis, respectively (Fig. 3A). Their hemo-
lytic activities were in a dose-dependent manner as illustrated 
Table 1. Sequences and structural parameters of peptides 
name sequence net hydrophobicity hydrophobic moment polar residues (n%) nonpolar residues (n%)
LR1 RIKRFWPVVIRTVVAGYNLYRAIKKK ‘+8 0.421  0.406  11/42.31 15/57.69 
LR2 RIKRFWPVVIRTVVAGYNLYRAIKK ‘+7 0.477 0.412 10/40 15/60
LR3 RIKRFWPVVIRTVVAGYNLYRAIK ‘+6 0.538  0.391  9/37.5 15/62.5 
LR4 RIKRFWPVVIRTVVAGYNLYRAI ‘+5 0.605  0.435  8/34.78 15/65.22 
LR5 RIKRFWPVVIRTVVAGYNLYRA ‘+5 0.550  0.407  8/36.36 14/63.64 
LR6 RIKRFWPVVIRTVVAGYNLYR ‘+5 0.562  0.441  8/38.1 13/61.9 
LR7 RIKRFWPVVIRTVVAGYNLY ‘+4 0.640 0.456 7/35 13/65
LR8 RIKRFWPVVIRTVVAGYNL ‘+4 0.624  0.430  7/36.84 12/63.16 
LR9 RIKRFWPVVIRTVVAGYN ‘+4 0.564  0.490  7/38.89 11/61.11 
LR10 RIKRFWPVVIRTVVAGY ‘+4 0.632  0.492  6/35.29 11/64.71 
LR11 RIKRFWPVVIRTVVAG ‘+4 0.612  0.478  6/37.5 10/62.5 
LR12 RIKRFWPVVIRTVVA ‘+4 0.653  0.510  5/33.33 10/66.67 
LR13 RIKRFWPVVIRTVV ‘+4 0.677  0.566  5/35.71 9/64.29 
LR14 RIKRFWPVVIRTV ‘+4 0.635  0.638  5/38.46 8/61.54 
LR15 RIKRFWPVVIRT ‘+4 0.587  0.592  5/41.67 7/58.33 
LR16 RIKRFWPVVIR ‘+4 0.616  0.645  4/36.36 7/63.64 
RL1 IKRFWPVVIRTVVAGYNLYRAIKKK ‘+7 0.478  0.425  10/40 15/60 
RL2 KRFWPVVIRTVVAGYNLYRAIKKK ‘+7 0.423  0.372  10/41.67 14/58.33 
RL3 RFWPVVIRTVVAGYNLYRAIKKK ‘+6 0.484  0.368  9/39.13 14/60.87 
RL4 FWPVVIRTVVAGYNLYRAIKKK ‘+5 0.552  0.348  8/36.36 14/63.64 
RL5 WPVVIRTVVAGYNLYRAIKKK ‘+5 0.493  0.306  8/38.1 13/61.9 
RL6 PVVIRTVVAGYNLYRAIKKK ‘+5 0.406  0.260  8/40 12/60 
RL7 VVIRTVVAGYNLYRAIKKK ‘+5 0.389  0.311  8/42.11 11/57.89 
RL8 VIRTVVAGYNLYRAIKKK ‘+5 0.343  0.337  8/44.44 10/55.56 
RL9 IRTVVAGYNLYRAIKKK ‘+5 0.291  0.285  8/47.06 9/52.94 
RL10 RTVVAGYNLYRAIKKK ‘+5 0.197  0.334  8/50 8/50 
RL11 TVVAGYNLYRAIKKK ‘+4 0.277  0.304  7/46.67 8/53.33 
RL12 VVAGYNLYRAIKKK ‘+4 0.279  0.311  6/42.86 8/57.14 
RL13 VAGYNLYRAIKKK ‘+4 0.206  0.300  6/46.15 7/53.85 
RL14 AGYNLYRAIKKK ‘+4 0.122 0.427 6/50 6/50
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in Fig. 3B. LR8–11, RL6, and RL14 did not show hemolytic 
ability in this experiment. 
LR2 (MIC against four tested microorganism strains was 
3.516, 4.688, 9.375, and 2.344 g/mL, respectively) and LR3 
(MIC against four tested microorganism strains was 2.344, 
4.688, 7.032, and 0.586 g/ml, respectively) showed stronger 
antimicrobial abilities than the native cathelicidin Pc-CATH1 
(LR1, MIC against four tested microorganism strains was 
9.375, 18.75, 9.375, and 7.032 g/mL). Especially, LR3 
showed much stronger antimicrobial activities than LR1 
although LR3 just has six positively charged residues. Table 1 
showed that hydrophobicity degree among these three peptides 
is LR3 (0.538) > LR2 (0.477) > LR1 (0.421). Coincidently, 
antimicrobial activity among these three peptides is LR3 > 
LR2 > LR1. It seems that the hydrophobicity is positively 
correlated with antimicrobial ability in these three peptides. 
LR4–6 lost their three lysines positioned at the C-terminus and 
had only 5 net positive charges, which obviously increased the 
hydrophobicity (0.605, 0.550, and 0.562, respectively) and 
resulted in losing amphipathicity at the C-terminus. Decreased 
net positive charge and the lacking of amphipathicity at the  
C-terminus may contribute to their decreased antimicrobial 
and hemolytic activities. Other LR peptides had a little -helix 
ratio (Fig. 2), which possibly result in weak antimicrobial and 
hemolytic activities.   
Several RL (RL1–5) peptides showed stronger antimicrobial 
and hemolytic activities than LR1–5 although they had similar 
length and net positive charges. RL1–5 had weaker 
hydrophobicity and hydrophobicity moment than LR1–5, 
which are possible contributable for the strong antimicrobial 
and hemolytic abilities of RL1–5. RL6 is less one residue (Trp) 
at the N-terminus than RL5. There are higher percent α-helical 
structure component in RL6 (62%) than in RL5 (42%) while 
the antimicrobial activities of RL6 was much weaker than 
those of RL5 (Fig. 2, Table 2). It has been found that 
hydrophobicity of RL6 (0.406) is lower than that of RL5 
(0.493). The hydrophobicity of RL6 is so low that it is difficult 
to keep its amphipathicity as illustrated in Fig. 1. The 
tryptophan residues in some antimicrobial peptides including 
melittin, IsCT, papiliocin, and mastoparan B have been 
reported to be critical for their antibacterial and/or hemolytic 
activities7-10. In those antimicrobial peptides, the tryptophan 
residues are located in the hydrophobic core of the peptides, 
exhibit restricted motion in bacterial membrane, and are 
involved in hydrophobic interactions with the acyl chains of 
the membrane phospholipid7–10. As illustrated in Fig. 1, the 
tryptophan residues in RL peptides are located in the 
hydrophobic core of the peptides while RL6 lacks tryptophan. 
The absence of tryptophan and low degree of amphipathicity 
 
Figure 1.  Helix-wheel plots of cathelicidin Pc-CATH1 and its homologues. The hydrophobic residues are indicated in gray, and the 
hydrophilic residues are shown in black. 
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in RL6 may result in its low antimicrobial activities. 
The hemolytic activity between RL4 and RL5 had big 
difference although there is only one amino acid residue (Phe) 
difference between them (Table 1). At the concentration of 
200 g/mL, RL4 induced 57% hemolysis while RL5 only 
induced 8% hemolysis. For RL4, there is one additional Phe 
extension at the N-terminus of RL5. Beside its involvement in 
antimicrobial ability, tryptophan residues in antimicrobial 
peptides were also reported to be involved in hemolytic 
activities7–9. The tryptophan is located the position 2 and the 
position 1 at the N-terminus of RL4 and RL5, respectively 
(Table 1). The tryptophan residue located at the position 1 
should be more flexible than the tryptophan residue located at 
the position 2. Therefore, the anchoring ability of Trp1 into the 
membrane of blood red cells might be weaker than that of 
Trp2. In addition, phenylalanine residue has also ability to 
anchor into the membrane of blood red cells, the deletion of 
phenylalanine in RL5 can also decrease its hemolytic activity. 
The current work investigated the structure-function  
relationship of antimicrobial peptide cathelicidin Pc-CATH1 
to screen peptide candidates with potential antimicrobial  
abilities and low hemolytic activities. Some cathelicidin  
Pc-CATH1 homologues such as LR4 and RL5 have been 
found to be potent templates for developing antibiotics. Their 
structure-function relationships responsible for antimicrobial 
and hemolytic activities will be investigated further. 
 
Experimental Section 
General Experimental Procedures. The analysis for helix-
wheel diagrams, net charge, hydrophobicity, hydrophobicity 
moment, polar residues, and nonpolar residues were carried 
out by the software package provided by The Expert Protein 
Analysis System (ExPASy) proteomics server according to the 
method described by Gautier et al11. (http://heliquest.ipmc.cnrs.
fr/). The experiments and data analysis of circular dichroism 
(CD) were performed at 298 K using a JASCO J-810 spectro-
polarimeter (Jasco, Japan). 
 
 
Figure 2.  CD spectra of peptides (90 μM, pH 5.5) in H2O (A), 30 (B), and 60 mM (C) SDS micelles micelles. These values 
represent mean values of three independent experiments. 
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Experimental Material. Cathelicidin Pc-CATH1 and its 29 
homologues (Table 1) were synthesized by GL Biochem 
(Shanghai) Ltd. (Shanghai, China). Their purity was  
confirmed higher than 98% by HPLC and mass spectrometry 
analysis. 
 
Hemolytic Activities. The hemolytic activities of cathelicidin
Pc-CATH1 and its 29 homologues against human red blood 
cells were tested in Alsever's solution (in g/L: NaCl, 4.2; citric 
Acid·3Na·2H2O, 8.0; citric Acid·H2O, 0.55; D-glucose, 20.5) 
as reported12. Fresh human red blood cells were washed three 
times with Alsever's solution by centrifugation for 10 min at 
1000  g. The washed human red blood cells were resuspended
in Alsever's solution. The tested samples (resolved in 50 L 
Alsever's solution) were mixed with 50 L human red blood 
cells in Alsever's solution. The final erythrocyte concentration 
is 4% (v/v). The resulting solution was incubated at 37 oC for 
30 min. Red cells were centrifuged at 1000  g for 5 min and 
the absorbance of the supernatant was measured at 595 nm. 
100% hemolysis was determined by adding 0.1% Triton  
X-100 to a sample of cells. 
 
Circular Dichroism Analysis. Samples were prepared by 
dissolving tested peptide powders (90 µM) in membrane-
mimetic environments (SDS micelles of different concentra-
tions). The CD spectra of the peptides were recorded at 25 °C. 
The spectra were measured between 190 and 250 nm using  
0.1 cm path-length cell with 0.1 nm bandwidth. The response 
time is 1 sec; the scan speed is 100 nm/min. Ten consecutive 
scans were performed for each sample. The data from ten 
scans were averaged and smoothed using J810 software. The 
secondary structure elements of the peptides were estimated 
according to the Yang formula13. 
 
Antimicrobial Testing. Gram-positive bacterium Staphylo-
coccus aureus (ATCC25923), Bacillus subtilis Gram-negative 
bacteria Escherichia coli ATCC25922, and fungus Candida 
albicans (ATCC2002) were obtained from Kunming Medical 
College (Yunnan, China). Antimicrobial assay was carried out 
according to our previous method14,15. Microorganisms were 
first cultured in LB (Luria-Bertani) broth. When the absorbance
of the culture at 600 nm was up to 0.8, a 10 L aliquot of the 
microorganism culture was then taken and mixed with 8 mL of 
fresh LB broth with 0.7% agar (upper agar). The upper agar 
was poured onto a 90 mm Petri dish containing 25 mL of 1.5% 
agar in LB broth (lower agar). A 20 L aliquot of the test 
sample filtered on a 0.22 m was dropped onto strips of 
 
Figure 3.  Hemolytic activities of cathelicidin Pc-CATH1 and its homologues against human blood red cells. A: Hemolytic 
activities of peptides at concentration of 200 g/mL; B: hemolytic activities of LR1–6 and RL1–6 at concentration of 50, 100, 
and 200 g/mL, respectively. These values represent mean values of three independent experiments. 
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Whatman no. 3 filter paper with a diameter of 0.3 cm. The 
strips were allowed to dry at room temperature for approxi-
mately 2 h and put on the surface of the hardened upper agar. 
If an examined sample contained antimicrobial activity, a clear 
zone formed on the surface of the top agar representing  
inhibition of microorganism growth. MICs (minimal inhibitory 
concentration) of tested samples against these microorganisms 
were determined using a broth microdilution assay as our  
previous reports15,16. The MIC was defined as the lowest  
concentration of test peptides inhibiting microorganism growth. 
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Table 2. Antimicrobial activities of cathelicidin Pc-CATH1 and 




E. coli B. subtilis S. aureus C. albicans 
ampicillin 2.344 9.375 37.5 0.146 
LR1 9.375 18.75 9.375 7.032 
LR2 3.516 4.688 9.375 2.344 
LR3 2.344 4.688 7.032 0.586 
LR4 9.375 37.5 37.5 2.344 
LR5 4.688 N 75 4.688 
LR6 9.375 N N 9.375
LR7 150 N N 112.5 
LR8 200 N N 75 
LR9 N N N 150 
LR10 N N N 75 
LR11 N N N 150 
LR12 N N N N 
LR13 N N N 150 
LR14 N N N N 
LR15 N N N 150 
LR16 N N N 150 
RL1 9.375 2.344 3.516 0.586
RL2 18.75 3.516 3.516 0.586 
RL3 19.75 7.032 1.172 0.586 
RL4 28.125 3.516 1.172 0.879 
RL5 37.5 37.5 14.063 2.344 
RL6 N N 100 37.5 
RL7 N N N 56.25 
RL8 N N N 75 
RL9 N N N N 
RL10 N N N N 
RL11 N N N N
RL12 N N N N 
RL13 N N N N 
RL14 N N N N 
MIC: minimal inhibitory concentration. These concentrations 
represent mean values of three independent experiments  
performed in duplicates. N: no antimicrobial activity was found at 
the sample concentration up to 200 g/mL. 
